Baseline Severity of Parent-Perceived Inattentiveness Is Predictive of the Difference Between Subjective and Objective Methylphenidate Responses in Children with Attention-Deficit/Hyperactivity Disorder

Predictors of Placebo Response in Adults With Attention-Deficit/Hyperactivity Disorder

(2012) Jan K. Buitelaar et al.   JOURNAL OF CLINICAL PSYCHIATRY

Dose–Response Characteristics in Adolescents with Attention-Deficit/Hyperactivity Disorder Treated with OROS® Methylphenidate in a 4-Week, Open-Label, Dose-Titration Study

(2010) Jeffrey H. Newcorn et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Does Placebo Response Differ between Objective and Subjective Measures in Children with Attention-Deficit/Hyperactivity Disorder?

(2010) Calvin R. Sumner et al.   POSTGRADUATE MEDICINE

Predictors of treatment outcome in adults with ADHD treated with OROS® methylphenidate

(2010) Jan K. Buitelaar et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Variability of Response Time as a Predictor of Methylphenidate Treatment Response in Korean Children with Attention Deficit Hyperactivity Disorder

(2009) Seung-Hye Lee et al.   YONSEI MEDICAL JOURNAL

A Randomized, Placebo-Controlled Trial of Three Fixed Dosages of Prolonged-Release OROS Methylphenidate in Adults with Attention-Deficit/Hyperactivity Disorder

(2008) Rossella Medori et al.   BIOLOGICAL PSYCHIATRY